Skip to content
CiplaCiplaCipla459459459

Drawing based on the label description. No photo yet.

“Fenofibrate Tablets: 48 mg: Yellow coloured, oval shaped, biconvex film coated tablets, debossed with 'Cipla' on one side and code '459' on other side”

Cipla 459 pill

Pill with imprint Cipla 459 is yellow, oval, 12 mm and has been identified as Fenofibrate 48 mg. It is used for high cholesterol, high triglycerides and heart disease. It is supplied by Cipla USA Inc.

Fenofibrate 48 mg

Imprint
Cipla 459
Strength
48 mg
Used for
High cholesterol, high triglycerides and heart disease
Color
Yellow
Shape
Oval
Size
12 mm
Score
No score line
Form
Tablet
Manufacturer
Cipla USA Inc
Drug class
Peroxisome proliferator-activated receptor alpha agonist
NDC
69097-459, 69097-459-02, 69097-459-05, 50090-5327, 50090-5327-0, 51655-866, 51655-866-52, 71335-0891, 71335-0891-1, 71335-0891-2, 71335-0891-3

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Fenofibrate pills and guides

What is Fenofibrate used for?

Fenofibrate is used for high cholesterol, high triglycerides and heart disease.

Medicine type
Peroxisome proliferator-activated receptor alpha agonist
Official uses from the US prescribing label

Primary Hypercholesterolemia or Mixed Dyslipidemia

Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

Severe Hypertriglyceridemia

Fenofibrate tablets are also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. Improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention.

Markedly elevated levels of serum triglycerides (e.g. > 2,000 mg/dL) may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been adequately studied.

Important Limitations of Use

Fenofibrate at a dose equivalent to 160 mg of fenofibrate tablet was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes mellitus.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows Cipla and the other side shows 459.
  • It is yellow, oval, 12 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Fenofibrate

Inactive: Cellulose, Microcrystalline, Crospovidone, D&c Yellow No. 10, Docusate Sodium, Fd&c Blue No. 2, Fd&c Yellow No. 6, Hypromellose 2910 (3 Mpa.s), Lactose Monohydrate, Lecithin, Soybean, Magnesium Stearate, Polyvinyl Alcohol, Unspecified, Sodium Lauryl Sulfate, Sucrose, Talc, Titanium Dioxide, Xanthan Gum

Also distributed by

A-S Medication Solutions, Northwind Health Company, LLC, Bryant Ranch Prepack

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Fenofibrate pills